Acteoside Attenuates Oxidative Stress and Neuronal Apoptosis in Rats with Focal Cerebral Ischemia–Reperfusion Injury

  • Xia Dongjian
    Department of Neurosurgery, Beijing Tian Tan Hospital, Capital Medical University Department of Neurosurgery, the First Affiliated Hospital, Jinzhou Medical University
  • Zhang Zhuang
    Department of Neurology, the First Affiliated Hospital, Jinzhou Medical University
  • Zhao Yuanli
    Department of Neurosurgery, Beijing Tian Tan Hospital, Capital Medical University

この論文をさがす

説明

<p>Acteoside (ACT) has been shown to exert antioxidant and neuroprotective effects in neurodegenerative diseases. However, the effect of ACT on cerebral ischemia–reperfusion (I/R) injury is not yet clear. In this study, we found that ACT administration reduced infarct volume and brain edema, and improved neurological deficits, as indicated by the decreased modified neurological severity score. Administration of ACT strikingly reduced oxidative stress, accompanied by decreased levels of reactive oxygen species and malondialdehyde and increased levels of superoxide dismutase and catalase in a rat model of middle cerebral artery occlusion/reperfusion (MCAO/R). Furthermore, ACT administration reduced the number of terminal deoxynucleotidyl transferase uridine 5′-triphosphate (UTP) nick-end labeling-positive cells in the cerebral cortex of ischemic side of MCAO/R rats, accompanied by downregulation of B cell lymphoma 2 (Bcl-2) associated X protein and cleaved caspase-3 proteins and upregulation of Bcl-2 protein. Additionally, ACT treatment inhibited the protein kinase R/eukaryotic initiation factor-2α stress pathway in the brains of MCAO/R rats. Our results demonstrated that ACT attenuates oxidative stress and neuronal apoptosis in MCAO/R rats, suggesting that ACT may serve as a novel therapeutic candidate for the treatment of I/R brain injury.</p>

収録刊行物

被引用文献 (1)*注記

もっと見る

参考文献 (31)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ